Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kukje Pharma CoXKRX:002720 -0.74%61 Median PS Value is ₩6,383.48 as of Aug. 16, 2026, which is 100% below its 10-year median of 1.56. GuruFocus rates XKRX:002720 with a GF Score™ of 61/100 and a GF Value™ of ₩5,952.85 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 548 Drug Manufacturers companies, Kukje Pharma Co ranks better than 79.93% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Kukje Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₩8664.372. Kukje Pharma Co's 10-Year median PS Ratio is 0.7368. Therefore, the Median PS Value for today is ₩6,383.48.
As of today (2026-08-16), Kukje Pharma Co's share price is ₩3355.00. Kukje Pharma Co's Median PS Value is ₩6,383.48. Therefore, Kukje Pharma Co's Price to Median PS Value for today is 0.53.
The historical rank and industry rank for Kukje Pharma Co's Median PS Value or its related term are showing as below:
XKRX:002720'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53 Med: 1.56 Max: 2.71
Current: 0.53
During the past 13 years, the highest Price to Median PS Value of Kukje Pharma Co was 2.71. The lowest was 0.53. And the median was 1.56.
XKRX:002720's Price-to-Median-PS-Value is ranked better than 79.93% of 548
companies
in the Drug Manufacturers industry
Industry Median: 0.87
vs XKRX:002720: 0.53
Kukje Pharma Co (XKRX:002720) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Kukje Pharma Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
3355.00
/
6,383.48
=
0.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kukje Pharma Co Median PS Value Related Terms
Kukje Pharma Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Kukje Pharma Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kukje Pharma Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kukje Pharma Co Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kukje Pharma Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Kukje Pharma Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.7368.
Kukje Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8664.372.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kukje Pharma Co (XKRX:002720) has a Median PS Value of ₩6,383.48 as of Aug. 16, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Kukje Pharma Co and its competitors. This is 409097% above median its historical median of 1.56. Over the past decade, Kukje Pharma Co's Median PS Value has ranged from 0.53 to 2.71. According to the industry distribution chart, Kukje Pharma Co ranks #110 out of 548 companies in the Drug Manufacturers industry, placing it in the top 20.1%.
Is Kukje Pharma Co's Median PS Value too high?
Kukje Pharma Co's current Median PS Value of ₩6,383.48 is 409097% above median its 10-year median of 1.56. Over the past 10 years, this metric has ranged from a low of 0.53 to a high of 2.71. Based on the distribution chart, Kukje Pharma Co ranks #110 out of 548 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kukje Pharma Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kukje Pharma Co's Median PS Value compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kukje Pharma Co ranks #110 out of 548 companies for Median PS Value. This places Kukje Pharma Co in the top 20% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.87. Historically, Kukje Pharma Co's own Median PS Value has ranged from 0.53 to 2.71 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.87, based on 548 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Kukje Pharma Co and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kukje Pharma Co's current Median PS Value is ₩6,383.48, which is 409097% above median its own 10-year median of 1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kukje Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Kukje Pharma Co (XKRX:002720) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,952.85, compared to a current price of ₩3,355.00 — trading 43.6% below its estimated fair value. The current Median PS Value is ₩6,383.48, which is 409097% above median its 10-year median of 1.56. Kukje Pharma Co's overall GF Score™ is 61/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Kukje Pharma Co (XKRX:002720), the current Median PS Value is ₩6,383.48 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kukje Pharma Co (XKRX:002720) Overvalued in 2026?
Based on GuruFocus' analysis, Kukje Pharma Co stock appears to be undervalued.
The current stock price of ₩3,355.00 is trading 43.6% below its estimated GF Value™ of ₩5,952.85.
GuruFocus considers Kukje Pharma Co to be Possible Value Trap.
Key valuation signals for XKRX:002720:
Median PS Value: ₩6,383.48 (409097% above median its 10-year median of 1.56)
GF Value™: ₩5,952.85 vs. price of ₩3,355.00 (43.6% below fair value)
No single metric tells the full story. See the XKRX:002720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kukje Pharma Co Ltd is engaged in the manufacturing and sales of pharmaceutical products, and it handles over-the-counter and prescription drugs such as Q-Allon eye drops, Letium tablets, Ezerova tablets, Colencia soft capsules, and International Cephazedon injection.
61GF Score
Get the complete analysis for XKRX:002720
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:002720 has been successfully added to your 
